JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardner, R. M.
Right arrow Articles by Stancel, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardner, R. M.
Right arrow Articles by Stancel, G. M.

Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid

RM Gardner and GM Stancel

Department of Biology, Villanova University, Pennsylvania.

Epidermal growth factor (EGF) induces uterine contractions in an in vitro system. As an initial approach to elucidating the cellular mechanism for this action of EGF, we have characterized this effect pharmacologically in uteri from castrate, estrogenprimed mature rats. EGF-induced contractions are observed in both intact tissue and isolated myometrium, are dependent on extracellular calcium and are inhibited by nifedipine and chlorpromazine. Both indomethacin and nordihydroguaritic acid (NGA) inhibit EGF-induced uterine contractions. At the maximum doses which do not affect contractile responses to prostaglandin E2 or carbachol, indomethacin (10 microM) alone or NGA (1 microM) alone only decrease the effect of EGF by 60 to 80%, but indomethacin and NGA in combination abolish totally the response to the growth factor. Arachidonic acid also causes uterine contractions in this system. EGF increases uterine contractions in the presence of a submaximal (1 microM) but not a maximal (10 microM) dose of arachidonic acid. These findings suggest that EGF-induced contractions result from a mobilization of myometrial arachidonic acid, production of intermediates via both lipoxygenase and cyclooxygenase catalyzed pathways and a resultant influx of extracellular calcium.

Volume 250, Issue 3, pp. 882-886, 09/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 EndocrinologyHome page
A. Kimura, M. Ohmichi, T. Takeda, H. Kurachi, H. Ikegami, K. Koike, K. Masuhara, J. Hayakawa, T. Kanzaki, M. Kobayashi, et al.
Mitogen-Activated Protein Kinase Cascade Is Involved in Endothelin-1-Induced Rat Puerperal Uterine Contraction
Endocrinology, February 1, 1999; 140(2): 722 - 731.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. R. Gargiulo, F. S. Khan-Dawood, and M. Y. Dawood
Epidermal Growth Factor Receptors in Uteroplacental Tissues in Term Pregnancy before and after the Onset of Labor
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 113 - 117.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics.